Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina

Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), necessitates effective management strategies. This study aims to evaluate the real-world efficacy of vedolizumab, a newer biological therapy, in treating IBD in Bosnia and Herzegovina. A retrospect...

Full description

Bibliographic Details

Published in:	Biomolecules & Biomedicine
Main Authors:	Nermin Salkić, Mirela Bašić Denjagić, Nađa Zubčević, Renata Tamburić, Azra Husić Selimović, Emil Babić, Milenko Bevanda, Aida Saray, Predrag Jovanović, Zoran Tošić, Aleksandar Dobrovoljski, Tatjana Barać
Format:	Article
Language:	English
Published:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2024-04-01
Subjects:	Inflammatory bowel disease (IBD) vedolizumab Crohn's disease (CD) ulcerative colitis (UC) real-world efficacy
Online Access:	https://www.bjbms.org/ojs/index.php/bjbms/article/view/10433